Lu et al. found that the mRNA and protein levels of MCP-1 increased in a parallel time course to the development of cerebral vasospasm (peaked on day 5) in a rat double-hemorrhage model, suggesting that specific MCP-1 antagonists may be beneficial to prevent vasospasm caused by SAH [41]. This evidence concerns the gene CCL2 and hemorrhage.